Overview

Inflation Device Market Introduction

Inflation Device Market to value over US $ 680 million and grow at a CAGR of over 4.5% during the forecast period from 2020 to 2027.

 With an increase in the incidence of target diseases, given the high risk and exposure to chronic diseases due to an unhealthy sedentary lifestyle and rising geriatric population, all these factors accelerate, promote and positively push the global market. Furthermore, adding to these factors, beneficial medical reimbursement for minimally invasive procedures in developed countries, advancing demand for minimally invasive surgical procedures across global powers, and increasing applications of inflation devices are the principal determinants driving the growth of the inflation devices market. Government initiatives to control the burden of healthcare-associated infections in developed countries and escalating healthcare expenditure across emerging markets are further assisting market growth.

In terms of market segmentation, in terms of the capacity segment, the global market is differentiated into 20ml, 30ml, and 60ml inflation devices. The 60ml inflation devices segment is anticipated to flourish at the most active CAGR during the forecast period. These devices have easy accessibility and mechanisms and are intended to be handy, which has promoted their application in various industries. Implementation of these devices in pulmonary, gastroenterology, and otolaryngology procedures is growing increasingly popular, as these techniques utilize comparatively larger-sized balloons and requires more liquid for inflation.

According to the application, the market is characterized by interventional cardiology, interventional radiology, peripheral vascular procedures, urological procedures, gastroenterological procedures, and other applications. Among these, the interventional cardiology segment valued for the most substantial share of the inflation device market. The mounting ageing population is more predisposed to develop CVD, which is a significant circumstance driving the adoption of interventional cardiology procedures that utilizes inflation devices. Furthermore, mushrooming in the quantity of new multi-specialty hospitals in developing countries offering advanced minimally invasive procedures, promising reimbursement scenario for angioplasty procedures will additionally stimulate the growth of the division over the forecast period.

In terms of end-user, the hospitals and clinics segment is the largest contributor to the inflation devices market due to the expanding amount of hospitals and specialty clinics in developing nations, the growing predominance of target diseases; and a considerable number of surgical and diagnostic procedures implemented across these amenities.

Asia Pacific is anticipated to advance at the highest CAGR in the market during the forecast period. North America is foreseen to value for the most considerable share in the global market. Business germination is motivated by the increasing frequency of minimally invasive surgical procedures, advancing healthcare infrastructure, rising awareness about HAIs and the use of disposable devices, and the increasing adoption of minimally invasive procedures.

Major market companies operating globally are:

Merit Medical Systems, Boston Scientific Corporation, Cardinal Health, CONMED Corporation, Medtronic plc, Acclarent Inc., Cook Medical, Atrion Corporation, Becton, Dickinson and Company, Terumo Medical Corporation, B. Braun Melsungen AG, Olympus Corporation, Teleflex Incorporated, and US Endovascular.

Major market firms are undertaking strategic initiatives to increase their presence in emerging countries to leverage the growth opportunities in these markets will further contribute to the market growth.

Market Segmentation

By Capacity

• 20ml Inflation Devices
• 30ml Inflation Devices
• 60ml Inflation Devices

By Display Type

• Analog Inflation Devices
• Digital Inflation Devices

By Application

• Interventional Cardiology
• Interventional Radiology
• Peripheral Vascular Procedures
• Gastroenterological Procedures
• Urological Procedures
• Other Applications

By End User

• Hospitals and Clinics
• Ambulatory Surgery Centers

By Region:

• Europe
• North America
• APAC
• Latin America
• Rest of World

Competitive Landscape:

●      Tier 1 players- established companies in the market with a major market share

●      Tier 2 players

●      Emerging players which are growing rapidly

●      New Entrants 

FutureWise Takeaways

●      Growth prospects

●      SWOT analysis

●      Key trends

●      Key data points affecting market growth

Objectives of the Study:

●     To provide an exhaustive analysis on the global market by capacity, by display type, by application, by end-user, and by region

●      To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)

●      To evaluate and forecast micro-markets and the overall market

●      To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the rest of the world

●      To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions

●      Profiling of companies to evaluate their market shares, strategies, financials and core competencies

Table of Contents

1. Market Introduction
        1.1. Objectives of the Study 
        1.2. Market Definition 
        1.3. Market Scope 
               1.3.1. Years Considered for the Study
               1.3.2. Market Covered
        1.4. Currency 
        1.5. Limitations 
        1.6. Stakeholders 
 2.  Research Methodology 
        2.1. Research Data 
               2.1.1. Secondary Data
                          2.1.1.1. Key Data from Secondary Sources
               2.1.2. Primary Data
         2.1.2.1. Key Data from Primary Sources
        2.2. Market Size Estimation 
        2.3. Market Breakdown and Data Triangulation 
        2.4. Assumptions for the Study  
3. Executive Summary
        3.1. Market Outlook
        3.2. Segment Outlook
        3.3. Competitive Insights
4. Global Inflation Device Market Variables, Trends & Scope
        4.1. Market Lineage Outlook
        4.2. Penetration and Growth Prospect Mapping
        4.3. Industry Value Chain Analysis
        4.4. Cost Analysis Breakdown
        4.5. Technology Overview
        4.6. Regulatory Framework
                 4.6.1. Reimbursement Framework
                 4.6.2. Standards and Compliances
5. Global Inflation Device Market Overview
        5.1. Market Dynamics
                  5.1.1. Market Driver Analysis
                            5.1.1.1. Increasing focus of Inflation Device Companies on Brand Protection
                            5.1.1.2. Untapped Opportunities in Emerging Regions
                  5.1.2. Market Restraint Analysis
                            5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
                  5.1.3. Industry Challenges
                            5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Inflation Device Market Analysis Tools
        6.1. Industry Analysis - Porter’s
               6.1.1. Supplier Power
               6.1.2. Buyer Power
               6.1.3. Substitution Threat
               6.1.4. Threat from New Entrants
               6.1.5. Competitive Rivalry
        6.2. Pestel Analysis
               6.2.1. Political Landscape
               6.2.2. Environmental Landscape
               6.2.3. Social Landscape
               6.2.4. Technology Landscape
               6.2.5. Legal Landscape
        6.3. Major Deals And Strategic Alliances Analysis
                6.3.1. Joint Ventures
                6.3.2. Mergers and Acquisitions
                6.3.3. Licensing and Partnership
                6.3.4. Technology Collaborations
                6.3.5. Strategic Divestments
        6.4. Market Entry Strategies
        6.5. Case Studies
7. Global Inflation Device Market, By Capacity Historical Analysis and Forecast 2020-2027 (USD Million)
        7.1. 20ml Inflation Devices
        7.2. 30ml Inflation Devices
        7.3. 60ml Inflation Devices
8. Global Inflation Device Market, By Display Type Historical Analysis and Forecast 2020-2027 (USD Million)
        8.1. Analog Inflation Devices
        8.2. Digital Inflation Devices
9. Global Inflation Device Market, By Application Historical Analysis and Forecast 2020-2027 (USD Million)
        9.1. Interventional Cardiology
        9.2. Interventional Radiology
        9.3. Peripheral Vascular Procedures
        9.4. Gastroenterological Procedures
        9.5.  Urological Procedures
        9.6. Other Applications
10. Global Inflation Device Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million)
        10.1. Hospitals and Clinics    
        10.2. Ambulatory Surgery Centers
11. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
        11.1. Introduction
        11.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
                  11.2.1. U.S.A
                  11.2.2. Canada
                  11.2.3. Mexico
        11.3. Market Size (USD Million) Forecast for North America 2020-2027 
12. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
        12.1. Introduction
        12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
                 12.2.1. Brazil
                 12.2.2. Venezuela
                 12.2.3. Argentina
                 12.2.4. Rest of Latin America
        12.3. Market Size (USD Million) Forecast for Latin America 2020-2027  
13. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
        13.1. Introduction
        13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
                  13.2.1. Germany
                  13.2.2. U.K
                  13.2.3. France
                  13.2.4. Italy
                  13.2.5. Spain
                  13.2.6. Russia
                  13.2.7. Poland
                  13.2.8. Rest of Europe
        13.3. Market Size (USD Million) Forecast for Europe 2020-2027
14. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
        14.1. Introduction
        14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
                  14.2.1. Japan
                  14.2.2. China
                  14.2.3. India
                  14.2.4. Australia and New Zealand
                  14.2.5. ASEAN
                  14.2.6. Rest of Asia Pacific
        14.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027
15. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
        15.1. Introduction
        15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
                  15.2.1. Saudi Arabia
                  15.2.2. UAE
                  15.2.3. South Africa
                  15.2.4. Egypt
        15.3. Market Size (USD Million) Forecast for MEA 2020-2027           
16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts)
    16.1 Merit Medical Systems
            16.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.1.2. Product Portfolio
            16.1.3. SWOT Analysis
            16.1.4. Financial Overview
            16.1.5. Strategic Overview
    16.2 Boston Scientific Corporation
            16.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.2.2. Product Portfolio
            16.2.3. SWOT Analysis
            16.2.4. Financial Overview
            16.2.5. Strategic Overview
    16.3 Cardinal Health
            16.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.2. Product Portfolio
            16.3.3. SWOT Analysis
            16.3.4. Financial Overview
            16.3.5. Strategic Overview
    16.4 CONMED Corporation
            16.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.4.2. Product Portfolio
            16.4.3. SWOT Analysis
            16.4.4. Financial Overview
            16.4.5. Strategic Overview
    16.5 Medtronic plc 
            16.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.5.2. Product Portfolio
            16.5.3. SWOT Analysis
            16.5.4. Financial Overview
            16.5.5. Strategic Overview
    16.6 Acclarent Inc.
            16.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.6.2. Product Portfolio
            16.6.3. SWOT Analysis
            16.6.4. Financial Overview
            16.6.5. Strategic Overview
    16.7 Cook Medical
            16.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.7.2. Product Portfolio
            16.7.3. SWOT Analysis
            16.7.4. Financial Overview
            16.7.5. Strategic Overview
    16.8 Atrion Corporation
            16.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.8.2. Product Portfolio
            16.8.3. SWOT Analysis
            16.8.4. Financial Overview
            16.8.5. Strategic Overview
    16.9. Becton
            16.9.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.9.2. Product Portfolio
            16.9.3. SWOT Analysis
            16.9.4. Financial Overview
            16.9.5. Strategic Overview
    16.10. Dickinson and Company
            16.10.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.10.2. Product Portfolio
            16.10.3. SWOT Analysis
            16.10.4. Financial Overview
            16.10.5. Strategic Overview
    16.11. Terumo Medical Corporation
            16.11.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.11.2. Product Portfolio
            16.11.3. SWOT Analysis
            16.11.4. Financial Overview
            16.11.5. Strategic Overview
    16.12. B. Braun Melsungen AG
            16.12.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.12.2. Product Portfolio
            16.12.3. SWOT Analysis
            16.12.4. Financial Overview
            16.12.5. Strategic Overview
    16.13. Olympus Corporation
            16.13.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.13.2. Product Portfolio
            16.13.3. SWOT Analysis
            16.13.4. Financial Overview
            16.13.5. Strategic Overview
    16.14. Teleflex Incorporated 
            16.14.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.14.2. Product Portfolio
            16.14.3. SWOT Analysis
            16.14.4. Financial Overview
            16.14.5. Strategic Overview
    16.15. US Endovascular
            16.15.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.15.2. Product Portfolio
            16.15.3. SWOT Analysis
            16.15.4. Financial Overview
            16.15.5. Strategic Overview
17. FutureWise SME Key Takeaway Points for Client

Tables

Figures